Related Experiment Video
Updated: Jan 16, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
GENEOnet: a breakthrough in protein binding pocket detection using group equivariant non-expansive operators
Giovanni Bocchi1, Patrizio Frosini2, Alessandra Micheletti3
1Department of Environmental Science and Policy, Università degli Studi di Milano, Via Celoria 10, 20133, Milano, Italy. giovanni.bocchi1@unimi.it.
GENEOnet, a new machine learning model, accurately detects protein binding pockets using Group Equivariant Non-Expansive Operators (GENEOs). It outperforms existing methods, offering efficient and explainable virtual screening for drug discovery.
Area of Science:
- Computational Biology
- Structural Bioinformatics
- Machine Learning in Drug Discovery
Background:
- Accurate protein binding pocket identification is crucial for structure-based virtual screening and drug discovery.
- Existing methods often face challenges with model complexity, parameter interpretability, and computational cost.
Purpose of the Study:
- To introduce GENEOnet, a novel machine learning model for volumetric protein pocket detection.
- To leverage Group Equivariant Non-Expansive Operators (GENEOs) for simplified model complexity and enhanced domain knowledge integration.
- To provide a more explainable and computationally efficient alternative for identifying potential drug binding sites.
Main Methods:
- GENEOnet utilizes Group Equivariant Non-Expansive Operators (GENEOs) for protein pocket detection.
- The model processes protein structures by converting empty space into a 3D grid of voxels.
- It identifies and ranks potential binding pockets based on voxel output values.
Main Results:
- GENEOnet demonstrates robust performance, even with limited training data (200 proteins).
- It surpasses state-of-the-art methods, achieving a [Formula: see text] score of 0.764 on the PDBbind test set, outperforming P2Rank (0.702).
- Case studies, like ABL1 kinase, show excellent agreement between GENEOnet predictions and experimental binding sites.
Conclusions:
- GENEOnet offers a powerful, efficient, and explainable approach to protein pocket detection.
- The model's reduced parameter count lowers training costs and enhances interpretability.
- GENEOnet represents a significant advancement for structure-based drug discovery and virtual screening applications.
More Related Videos
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Conserved Binding Sites
Protein-protein Interfaces
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Ligand Binding and Linkage

